Genes regulated in MPTP-treated macaques and human Parkinson's disease suggest a common signature in prefrontal cortex

[1]  E. Bézard,et al.  Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms , 2009, The Lancet Neurology.

[2]  Erwan Bezard,et al.  Sleep disorders in Parkinson's disease: The contribution of the MPTP non-human primate model , 2009, Experimental Neurology.

[3]  H. Reichmann,et al.  Beyond tremor and rigidity: non-motor features of Parkinson’s disease , 2009, Journal of Neural Transmission.

[4]  A. Bittner,et al.  Dopamine Depletion Induces Distinct Compensatory Gene Expression Changes in DARPP-32 Signal Transduction Cascades of Striatonigral and Striatopallidal Neurons , 2009, The Journal of Neuroscience.

[5]  H. Bergman,et al.  Pathophysiology of the basal ganglia and movement disorders: From animal models to human clinical applications , 2008, Neuroscience & Biobehavioral Reviews.

[6]  C. Da Cunha,et al.  Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease , 2008, Neuroscience.

[7]  B. Bioulac,et al.  A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France , 2007, Movement disorders : official journal of the Movement Disorder Society.

[8]  V. Dhawan,et al.  Changes in network activity with the progression of Parkinson's disease. , 2007, Brain : a journal of neurology.

[9]  L. Moran,et al.  Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson’s disease , 2006, Neurogenetics.

[10]  P. Hevezi,et al.  Gene expression analyses reveal molecular relationships among 20 regions of the human CNS , 2006, Neurogenetics.

[11]  D. Hansel,et al.  Competition between Feedback Loops Underlies Normal and Pathological Dynamics in the Basal Ganglia , 2022 .

[12]  E. Bézard,et al.  Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's disease , 2005, Neurobiology of Disease.

[13]  Howard J Federoff,et al.  Dysregulation of Gene Expression in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Substantia Nigra , 2004, The Journal of Neuroscience.

[14]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[15]  Claude Ghez,et al.  Learning networks in health and Parkinson's disease: Reproducibility and treatment effects , 2003, Human brain mapping.

[16]  E. Bézard,et al.  Microarray analysis of nonhuman primates: validation of experimental models in neurological disorders , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Erwan Bezard,et al.  Presymptomatic compensation in Parkinson's disease is not dopamine-mediated , 2003, Trends in Neurosciences.

[18]  P. Strick,et al.  Basal-ganglia 'projections' to the prefrontal cortex of the primate. , 2002, Cerebral cortex.

[19]  S. Leurgans,et al.  Loss of basal forebrain P75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease , 2002, The Journal of comparative neurology.

[20]  B Bioulac,et al.  Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease , 2001, The Journal of Neuroscience.

[21]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[22]  E. Bézard,et al.  Upregulation of Striatal Preproenkephalin Gene Expression Occurs before the Appearance of Parkinsonian Signs in 1-Methyl-4-phenyl- 1,2,3,6-tetrahydropyridine Monkeys , 2001, Neurobiology of Disease.

[23]  E. Bézard,et al.  Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  G. Wilcock,et al.  Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease. , 1999, Biochemical and biophysical research communications.

[25]  E. Tolosa,et al.  BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. , 1999, Journal of neuropathology and experimental neurology.

[26]  E. Bézard,et al.  Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms , 1999, The European journal of neuroscience.

[27]  E. Bézard,et al.  Compensatory mechanisms in experimental and human Parkinsonism: towards a dynamic approach , 1998, Progress in Neurobiology.

[28]  Douglas M. Bowden,et al.  A Stereotaxic Template Atlas of the Macaque Brain for Digital Imaging and Quantitative Neuroanatomy , 1996, NeuroImage.

[29]  Mark W. Mahowald,et al.  Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder , 1996, Neurology.

[30]  T. Ishikawa,et al.  The Metabolic Topography of Parkinsonism , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  O. Hornykiewicz,et al.  Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey , 1991, Neuroscience.

[32]  A. Grace,et al.  Compensations after lesions of central dopaminergic neurons: some clinical and basic implications , 1990, Trends in Neurosciences.

[33]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[34]  W. Cowan,et al.  A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis) , 1984, The Journal of comparative neurology.

[35]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[36]  E. Hirsch,et al.  Neuronal vulnerability in Parkinson's disease. , 1997, Journal of neural transmission. Supplementum.

[37]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.